Pharmalot… Pharmalittle… Morning Edition
Make a commentBy Ed Silverman // November 18th, 2008 // 6:45 am
We are reminded to again share with you a favorite saying of the morning mayor: Every brand new day should be unwrapped like a precious gift. So go ahead, tug on the ribbon. And then, digest a few items while we hustle the short people off to the schoolhouse…
Fitch Slashes Merck Outlook To Negative (Press Release)
Most Zyrtec Users Didn’t Switch To OTC (Medical Marketing & Media)
Genentech Reports Another PML Case With Raptiva (PharmaTimes)
Judge Tosses Paxil Case (The Legal Intelligencer)
Novartis Fund Is Not A Venture Capitalist (Xconomy.com)
Merck Drug Fails To Slow Alzheimer’s (Yahoo/Reuters)
Recession Won’t Hurt CROs In India (The Economic Times)
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Alzheimers, CRO, Genentech, GlaxoSmithKline, India, Merck, Novartis, OTC, Paxil, Raptiva, Venture Capital, Zyrtec